Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03979
Species: Homo sapiens
Position : chr3:128603821-128604120
Year: 2014
Title: A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2)
PMID:  24703711
MONDO: MONDO:0018874
Tissue: bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: inv(3)/t(3
Cell Type: myeloid leukemia cell
Experiment Type: Endogenous enhancer-hijacking functional validation
High Throughput Method: ChIP-seq; RNA-seq; chromatin-conformation analysis
Low Throughput Method: Genomic enhancer excision; genome engineering; RT-qPCR; differentiation assay
About Target Gene
Target gene : MECOM
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 5 found
Enhancer ID Position Tissue Cell Disease
E_00340 chr3:128603426-128604425 bone marrow myeloid leukemia blast cell acute myeloid leukemia
E_00392 chr3:128603426-128604425 bone marrow myeloid leukemia blast cell acute myeloid leukemia
E_00418 chr3:128603426-128604425 blood CD34-positive hematopoietic stem/progenitor cell NA
E_03951 chr3:128603821-128604120 bone marrow myeloid leukemia cell acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2)
E_04324 chr3:128603821-128604120 bone marrow hematopoietic stem/progenitor cell acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2)
Expression of Target Genes for the Enhancer